US · Healthcare

Scopus Biopharma Inc (SCPS)

Biotechnology

Scopus Biopharma Inc (SCPS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SCPS

P/E ratio

25.00

Scopus Biopharma Inc (SCPS) — FAQ

What is SCPS's P/E ratio?

The price-to-earnings (P/E) ratio for Scopus Biopharma Inc (SCPS) is 25.00 (data as of 2026-05-23).

Does Scopus Biopharma Inc pay a dividend?

Dividend yield is not available in the current snapshot for Scopus Biopharma Inc (SCPS). Check the MyAverix Finance app for the latest dividend data.

What sector is Scopus Biopharma Inc in?

Scopus Biopharma Inc (SCPS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is SCPS listed on?

SCPS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)